Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

Natalie Muth, MD, MPH, RDN, is an adjunct associate professor at UCLA Fielding School of Public Health; co-founder of Namio ...

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...

GLP-1 drugs like Ozempic and Wegovy are revolutionizing single life by enhancing confidence, reshaping dating habits, and ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to ...

National Weight Loss Doctor Scott Masey joined Bloom Health Club to explain what GLP-1 drugs really do, and what most people aren’t being told. “These meds don’t just help with ...

Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, ...